Moving forward on Pharmacare for Canadians

24 May 2024 - Pharmacare legislation includes universal access to contraception and diabetes medications. ...

Read more →

Bausch Health announces additional public drug plan listings for Uceris (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults

23 May 2024 - Bausch Health today announced additional Canadian public drug plan listings for Uceris (budesonide) aerosol foam to ...

Read more →

PMPRB report examines availability and pricing of new medicines

22 May 2024 - The Patented Medicine Prices Review Board (PMPRB) published the eighth edition of its annual Meds Entry Watch ...

Read more →

Pfizer announces availability of Abrysvo in Canada for immunisation of pregnant individuals and adults 60+

22 May 2024 - Availability of Arbysvo is a major step in protecting infants and adults 60 years of age ...

Read more →

Health Canada approves Cosentyx, a biologic therapy, for the treatment of adults with moderate to severe hidradenitis suppurativa

22 May 2024 - Approval is based on the two largest Phase 3 trials conducted in hidradenitis suppurativa – SUNSHINE and SUNRISE ...

Read more →

The National Advisory Committee on Immunization recommends Beyfortus to protect all infants against RSV

21 May 2024 - The National Advisory Committee on Immunization issued a recommendation for Beyfortus (nirsevimab) to be used for the ...

Read more →

Health Canada approves Saladax’s 5-fluorouracil chemotherapy therapeutic drug monitoring test

14 May 2024 - Saladax Biomedical is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale ...

Read more →

ViiV Healthcare announces Health Canada approval for Apretude (cabotegravir tablets and extended release injectable suspension) for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV

13 May 2024 - The latest Canadian surveillance data shows that there were 1,833 new HIV diagnoses in 2022, a ...

Read more →

Health Canada approves Keytruda for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy

9 May 2024 - Approval is based on the Phase 3 KEYNOTE-966 Trial. ...

Read more →

When will Canada have national pharmacare?

22 April 2024 - Canadians support it, public health demands it, now policy makers must deliver it. ...

Read more →

Qulipta (atogepant) now approved by Health Canada for the preventive treatment of chronic migraine in adults

8 May 2024 - Approval was based on a pivotal Phase 3 clinical trial that demonstrated statistically significant reduction from baseline ...

Read more →

Health Canada approves Zoladex LA for the management of oestrogen receptor positive early breast cancer with a high risk of recurrence or advanced breast cancer in pre- and peri-menopausal women

7 May 2024 - TerSera Canada today announced that Health Canada has approved a supplemental new drug submission for Zoladex LA ...

Read more →

Wegovy (semaglutide injection) available in Canada

2 May 2024 - First and only Health Canada approved once weekly medication for chronic weight management ...

Read more →

CADTH is now Canada’s Drug Agency

1 May 2024 - As of today, we will adopt Canada’s Drug Agency (CDA-AMC) as our new operating name.  ...

Read more →

'What is the price of comfort?': Oncologist raises concerns about newly approved cancer treatment in Canada

30 April 2024 - A new cancer treatment recently approved in Canada promises to cut treatment time down to just ...

Read more →